|
مقاله
|
Abstract
|
|
|
|
Title:
|
Survey of keratometry and refractive error changes before and after Of Sub conjunctive mitomycin C injection in pterygium
|
|
Author(s):
|
Mohammad Hossein Davari,Hoda Gheytasi,Esmat davari
|
|
Presentation Type:
|
Poster
|
|
Subject:
|
Cornea and Anterior Segment
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Mohammad hossein Davari
|
|
Affiliation :(optional)
|
1. Atherosclerosis and coronary Artery Research center, Assistant Prof. of ophthalmology, Birjand University of Medical Sciences, Birjand, Iran., Vali-e-Asr Hospital ,Birjand, Birjand, Iran
|
|
E mail:
|
mhd_1337@yahoo.com
|
|
Phone:
|
0561-32404014
|
|
Mobile:
|
09151611115
|
|
|
|
|
Purpose:
|
To evaluate subconjunctival injection of mitomycin C (MMC) as safe and effective treatment
|
|
Methods:
|
This study was carried out from February 2008 to April 2010in eye clinic of Vali-e- Asre Hospital of Birjand University of Medical Sciences. 30 eyes with primary pterygia received 0.02 mg (MMC) (0.1 ml of 0.2 mg/ml solution,Kyowa Hakko Kogyo Co.Ltd.Tokyo,Japan ) sub conjunctively that injected into the body of the pterygium., patients were followed at 3 days, one week, one month, and six months after injection. Patients were examined at all visits for conjunctively Erythematic, epithelial defects, intraocular pressure, topography, keratometery and another complication. (Complete slit-lamp examinations).
|
|
Results:
|
The only complications after sub conjunctiva MMC injection were mild chemosis, long discomfort and redness in the site of injection for four days that were seen in six patients (20%). Toxicity of MMC was not observed in any case. The size of pterygia reduced in 83% of cases,) mean 0.41 mm (and progression were not seen in any case. The amount of astigmatism reduced in 70% cases (mean 0.46 diopter).
|
|
Conclusion:
|
Sub conjunctiva injection of MMC is an effective treatment and reduced redness and astigmatism.
|
|
Attachment:
|
4061poster 2015.pptx
|
|